A Targeted and pH-Responsive Nano-Graphene Oxide Nanoparticle Loaded with Doxorubicin for Synergetic Chemo-Photothermal Therapy of Oral Squamous Cell Carcinoma
DOI: https://doi.org/10.2147/IJN.S402249
IF: 7.033
2023-06-17
International Journal of Nanomedicine
Abstract:Ran Li, 1, 2, &ast Chen Liu, 1, 2, &ast Chaoqiong Wan, 1, 2 Tiantian Liu, 1, 2 Rongrong Zhang, 1, 2 Jie Du, 1 Xiangyu Wang, 1, 2 Xiaofeng Jiao, 1, 2 Ruifang Gao, 1, 2 Bing Li 1 1 Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials, Shanxi Medical University School and Hospital of Stomatology, Taiyuan, Shanxi, People's Republic of China; 2 Department of Pediatric and Preventive Dentistry, Shanxi Medical University School and Hospital of Stomatology, Taiyuan, Shanxi, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ruifang Gao; Bing Li, Email ; Purpose: Oral squamous cell carcinoma (OSCC) is a malignant disease with serious impacts on human health and quality of life worldwide. This disease is traditionally treated through a combination of surgery, radiotherapy, and chemotherapy. However, the efficacy of traditional treatments is hindered by systemic toxicity, limited therapeutic effects, and drug resistance. Fibroblast activation protein (FAP) is a membrane-bound protease. Although FAP has limited expression in normal adult tissues, it is highly expressed in the tumor microenvironment of many solid cancers – a characteristic that makes it an ideal target for anticancer therapy. In this study, we constructed a nano-drug delivery system () targeting FAP to increase the therapeutic efficiency of synergistic chemo-photothermal therapy against OSCC. Methods: We utilized PEGylated nano-graphene oxide (NGO) to link doxorubicin (DOX) and fluorescently-labeled, FAP-targeted peptide chains via hydrogen bonding and π–π bonding to enhance the targeting capability of The synthesis of was analyzed using UV–Vis and FT–IR spectroscopy and its morphology using transmission electron microscopy (TEM). Additionally, the drug uptake efficiency in vitro, photo-thermal properties, release performance, and anti-tumor effects of were evaluated and further demonstrated in vivo. Results: Data derived from FT–IR, UV–Vis, and TEM implied successful construction of the nano-drug delivery system. Confocal laser scanning microscopy images and in vivo experiments demonstrated the targeting effects of FAP on OSCC. Furthermore, exhibited a high photothermal conversion efficiency (52.48%) under near-infrared radiation. The thermogenic effect of simultaneously promoted local release of DOX and apoptosis based on a pH-stimulated effect. Importantly, FAP-targeted in combination with PTT showed better tumor suppression performance in vivo and in vitro than did either therapy individually. Conclusion: can precisely target OSCC, and combined treatment with chemical and photothermal therapy can improve the therapeutic outcomes of OSCC. This method serves as an efficient therapeutic strategy for the development of synergistic anti-tumor research. Keywords: fibroblast activation protein, nano-graphene oxide, photothermal therapy, oral squamous cell carcinoma, targeted combination therapy Oral squamous cell carcinoma (OSCC) is an aggressive cancer that accounts for 80–90% of oral malignancies. 1 Surgery combined with chemoradiotherapy remains the primary treatment. 2 While chemotherapy is necessary, it has several severe limitations, such as systemic toxicity, cancer recurrence, and developed drug resistance. This is mainly due to the untargeted systemic administration of chemotherapies, which can collect in non-cancerous tissues before reaching the tumor site. Therefore, it is necessary to develop an alternative targeted therapy. 3,4 Recently, researchers have shown an interest in the tumor microenvironment as a new target for chemotherapy. 5,6 Cancer-associated fibroblasts (CAFs) in the tumor microenvironment promote tumor growth and invasion. 7 Fibroblast activation protein (FAP) is overexpressed in CAFs. 8 FAP is a type II integrated membrane glycoprotein and a member of the dipeptidyl peptidase IV family, owing to its ability to cut Pro-XXX amino acid chains, which inhibit serine endopeptidases in the tumor microenvironment by acting on FAP. 9 Furthermore, many studies have shown that FAP may be a promising target for the design of tumor-targeting drugs and imaging agents. 10 Therefore, altering the tumor microenvironment of OSCC with FAP-targeted therapy may be an effective strategy to disrupt interactions within the microenvironment and selectively kill cancer cells. Over the past 20 years, tremendous efforts have been made to synthesize biomarkers that bind to nanosca -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology